Public drug policies Catalonia

Size: px
Start display at page:

Download "Public drug policies Catalonia"

Transcription

1 Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca

2 Catalonia Barcelona Territory: km2 Population: M Own language and culture

3 1. What s happened in Catalonia in the 80s 90s? 3

4 Mortality evolution by cause in Catalonia, Men and women aged 20 to 39 4

5 AIDS cases by transmission groups Catalonia

6 Costs of HCV, HBV, HIV for 10 EU countries prior to HCV combination therapy

7 2. Why? 7

8 Costs of HCV, HBV, HIV for 10 EU countries prior to HCV combination therapy

9 People on Methadone Annual breakdown

10 Needle Exchange Programme Coverage

11 Intervention Programme on Substance Abuse 11

12 What s the intervention modelin Catalonia? Public health perspective Public Health and Human Rights Perspective: Health maintenance and improvement of life quality Motivation to change (Proschaska and Di Clemente model) Diversity of services. Empowering drug users Magic and religious rituals Moral paradigm Healthcare model Health public model

13 The programme on Substance Abuse The Programme on Substance Abuse of the Government of Catalonia is in charge of drug policy planning, implementation and evaluation in the Region of Catalonia in Spain. Main objectives of the Programme: Surveillance of drug use and abuse and the morbimortality related to the use of drugs Definition of policies to deal with the problems related to drug consumptions and to treat people with substance disorders Financing drug resources to prevent, treat and reduce the harm related to drug use Evaluate the measures implemented in Catalonia.

14 Introducció Planning Tools MENTAL HEALTH DIRECTOR PLAN Assessment, planification and coordination tool about: Mental health promotion Prevention and treatment of mental and substance disorders and Prevenció i el tractament de les malalties associades amb la salut mental i les addiccions, Millora de la qualitat de vida dels afectats. PREVENTION PLAN IN CATALONIA DRUGS USE AND ASSOCIATED PROBLEMS Recull l estratègia nacional de prevenció del consum de drogues i problemes associats a Catalunya

15 Intervention areas Harm Reduction Harm reduction Based on a Public Health Model Programs: To prevent the risk of infectious diseases and overdoses between people who inject drugs. Working areas:; HR programs (NSP, OST, Overdose Prevention, DCRs, outreach work, HIV/HCV testing and access to treatment, Treatment Coordination of the Drug addiction care and treatment network (XAD). Prevention PROGRAM ON SUBSTANCE ABUSE Epidemiology Prevention programs: To reduce the prevalence of drug consumption. To delay the onset age of drug consumption. To avoid risky behaviors of experimental, occasional and regular drug users. Minimize the harms associated on drugs addiction. Working areas: community, family, working, education, leisure, health. Drug Dependence Information System in Catalonia (SIDC): Monitoring drug care centers (including HR services) School and household surveys Drug related Mortality Drug related Emergencies Infectious disease prevalence among PWID

16 Drug addiction care and treatment network Drop in centres: 16 (12 Drug Consumption room) Mobile Units: 6 (3 with DCR) Street work: 11 Detox units: 11 Beds: 65 Drug treatment centres 59 Therapeutic C. Units: 20 Places: 596 Dual Diagnosis Units: 5 Crisis Units: 1 Social rehabilitation centres: 12 day centres and 21 social rehabilitation schemes 140 Places on rehabilitation apartments 16

17 7 Key interventions ECDC & EMCDDA GUIDANCE. Prevention and control of infectious diseases among people who inject drugs. October Access to syringes and injecting material 2. Treatment for drug addiction: Opiates substitution treatment 3. Vaccinations 4. Screening of infections 5. Treatment of Infectious diseases 6. Health Education: safer injection, safer sex, BBV prevention,. 7. Combined interventions adapted to drug users and to the local conditions: outreach work, drop in centres, drug consumption rooms,... 17

18 Harm Reduction interventions in Catalonia Opioid substitution programme: people Syringe exchange programme (also in prisons): syringes/year Outreach work: Street work, Mobile units, Peer involvement, Low thereshold centres (drop in) with social and health care. Blood Borned Viruses tests & counselling (rapid tests) + HBV/HVA vaccinations. Access to HIV and Hepatitis treatment Supervised drug consumption rooms: syringes/year Training in a more hygienic consumption, safer sex... Action plan in drug trafficking and consumption areas Access to Health care system for all drug users Heroin trial Overdose Prevention Programme professionals trained users trained and naloxone vials distributed. Promotion and support of drug users and patient organisations 18

19 1 Opioid Sustitution Therapy Programme (OST) People in OST Programme Where? Source: Subdirecció General de Drogodependències. Departament de Salut CAS Drug treatment centres Primary care centers Mental Health care centers Harm Reduction Hospitals Community pharmacies Therapeutic communities Prisons 2 nd centers Meeting, Barcelona, June 1 st and 2 nd June,

20 2 Syringe Exchange Programme Evolution of the amount of distributed syringes Where? CAS Drug treatment centres Primary care centers Harm Reduction centers Hospitals Community pharmacies Prisons 20

21 2 Injecting risk Behaviors (last 6 months) % Injected with an used syringe Passed on a used syringe Shared paraphernalia Injecting drug users attending Harm Reduction facilities 21

22 3 Outreach work: Street work Professionals, mainly social workers, that work outdoors, in areas of consumption and socially deprivate. 11 Street work teams working in situ with active drug users who don t go to harm reduction resources. Actions: Dynamise the project "Snowball". Pickup of injection material in public spaces. Coordination and referral to social and health resources. Health education. 22

23 3 Outreach work: Mobile units Main objective: bring the social health services closer to the consumption areas and with high risk exclusion. 6 Mobile Units (3 with Drug Consumption Room) Actions: multiple actions and plans Opioid substitution therapy (OST) Consumption rooms Exchange syringes programme (PIJ) Place for health care Socio-educational care Monitoring the HIV, hepatitis C and tuberculosis treatment Preventing overdose by opioids and/or psychostimulants 23

24 4 Low thereshold centres (drop in) with social and health care Social and health services for active drug users Main objective: minimize the damages and risks related to drug use 16 centres 10 Actions: Social care Consumption room Syringe exchange programmes Opioid substitution therapy HIV, TBC and HC screening Health education Prevention of opiate and psychostimulants overdoses 24

25 25

26 5 Access to HIV and hepatitis treatment Main objective: Prevent, diagnose and facilitate the access to the treatment to those drug users infected by HIV and HCV. Actions: Training to professionals and users Edition of professional guides and awareness materials aimed at drug users. Awareness campaigns aimed to the general public. Monitoring of prevalence Early diagnosis (quick tests) Better Treatment for Ageing Drug Guidelines User to increase access to 2 nd Meeting, Barcelona, June 1 st and 2 nd June, Hepatitis 2017 C treatment for drug users 26

27 5 Prevalence among IDU recruited from Harm Reduction Facilities (antibody test HIV & HCV) The estimation of HIV incidence among new drug injectors (injecting during 5 years or less) is 8,71/100 cases/year and 25,6/100 in HCV cases (Folch C, 2012). 27

28 5 HIV diagnoses by transmission groups. Catalonia

29 6 Supervised drug Consumption Rooms Installations where people can consume with some privacy and under supervision of one or more professionals, who can help if necessary. Objectives: Preventing contagious diseases among its users. Preventing overdose. Facilitate the contact and the work with active drug dependence Facilitate the access to the treatment. Total: 12 9 in fix installations (2 with smoking room) + 3 in mobile units. 8 29

30 6 Supervised drug Consumption Rooms Material procured for the supervised consumption: Sterile syringe Distilled water Cup Filter Smart Alcohol pads 30

31 6 Supervised drug Consumption Rooms Number of CONSUMERS % are foreigners Better Injectors Treatment for Smokers Ageing Drug User 31

32 6 Supervised drug Consumption Rooms Number of CONSUMPTIONS Injections Better Treatment Smoked for Ageing consumptions Drug User 32

33 7 Training: Health care workshops for active drug users 6 teams provide health prevention trainings: Overdose prevention Safer sex, Safe injecting, 55 sessions/year More than 200 different users/year 34

34 8 Action plan in drug trafficking and consumption areas Demarcated areas or urban areas (neighborhood or set of streets) where there is all kind of consumptions in public places, mainly heroin and cocaine. Girona: 16 PIX points 1 HRS Often these areas are near traffic areas. Lleida: 1 HRS + 4 PIX points Reus: 2 HRS + 22 PIX points Constantí: 1 HRS + 1 PIX points Barcelona: 14 HRS + 70 PIX points El Prat de Llobregat: 2 HRS L Hospitalet de Llobregat: 1 HRS + 11 PIX points HRS: Harm Reduction Services: Harm Reduction Centers, Street work and/or Movbile units PIX points: Syringe Exchange programme (PIX) integrated in pharmacies, primary care centers, treatment centers, hospitals and Creu Roja Badalona: 1 HRS + 20 PIX points Sant Adrià de Besos: 1 HRS Gavà: 1 HRS + 4 PIX points 35

35 9 Access to Health System for all drug users. Immigrants without documentation. Guarantees access to public health and resources to treat drug addiction Active drug users by sex ( ) Women Men 36

36 0 Heroin Trial 37 37

37 11 Overdose prevention programme Programme to train drug users on overdose prevention and response. Drug users are trained by professionals in Drug Care Centres. Once trained, they are provided with a kit with naloxone professionals trained users trained naloxone vials distributed. 38

38 11 Mortality by acute adverse reaction to drugs. Barcelona

39 Drug user population Do get they older? 40

40 Admissions to treatment by main drug Treatment admissions by main drug % 12% 46% 14% 19% 4% Alcohol: 46% Cocaine: 19% Cannabis: 14% Heroine: 12% HEROÏNA COCAÏNA TABAC CÀNNABIS ALCOHOL ALTRES starts of treatment (2016) 41

41 Admissions to treatment by age Admissions to treatment by age de 71 a 99 anys 159 de 61 a 70 anys 706 de 51 a 60 anys 1893 de 41 a 50 anys de 31 a 40 anys de 26 a 30 anys de 18 a 25 anys de 11 a 17anys % males % females 52% over 40 y/o 42

42 Harmreduction services HRC users by age % 13% Over 40 y/o: % 35% 51% Under 39 years old y/o y/o Over 60 y/o HRC users 49% HRC users are over 40 y/o 43

43 Harmreduction services HRC users by residence statuts % 2% 3% 0% 3% 9% Houses, floors, apartments Homeless Occupied houses 41 % without or unstable residence 27% 54% Unstable accomodation Pensions,hotel,hostels Prison Another institutions Others, unknown xxxx % of them are more than 40 y/o 44

44 Visits in HRS by age visits (2016) 86 % males and 14 % females) Number of visits to HRS by age under 29 y/o 9% y/o 19% y/0 20% y/o y/o y/o 20% 14% 18% % visits: =+40 y/o 45

45 Drug users and homeless in Catalonia persons with unstable accomodation 31% (11.500) of them are homeless 40% of them with a mental disorder or addiction

46 Challenges Knowing more about the health and socials problems associated with the age becomes a priority: drugs users and/or people in treatment get older It s necessary to develop an specific attention plan for old drug users on an integral perspective. Nowadays the subject of this current European project is a challenge in Catalonia and surely in Spain: We have more and more ageing drug users (pick of the epidemic 80-90s) Many have chronic diseases (HIV / HCV epidemics), lack of education, not having worked much in their lifetime, Social benefits are very low in Catalonia: Only a rent of a month for people who have not worked. No housing, no food subsidies Support from parents. who are dying Economic crises means cuts on social benefits Positive thing: universal access to the health system, regardless of legal situation and tax contribution.

47 Thank you

Strategies of drug users to avoid infection with hepatitis C

Strategies of drug users to avoid infection with hepatitis C With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike

More information

Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain

Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain Prevalence of HIV, HCV and other sexually transmitted infections and associated risk behaviours among Spanish and immigrant IDU in Catalonia, Spain Folch C, Casabona J, Majó X, Brugal T, Meroño M, González

More information

Guidelines For Services Providing Injecting Equipment

Guidelines For Services Providing Injecting Equipment Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014

More information

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes PH52 Audit tool for the implementation of NICE public health guidance 52 Needle and syringe programmes Introduction This audit tool has been developed to help you audit implementation of, and compliance

More information

Drug Consumption Rooms Worldwide

Drug Consumption Rooms Worldwide Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR

More information

Substance use and misuse

Substance use and misuse An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan HARM REDUCTION WORKS FUND IT! National Report Summary Arguments for strategic investment With the support of The present document contains a summary of the key conclusions and recommendations provided

More information

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term

More information

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer Integrated harm reduction services for drug users and homeless people Katrin Schiffer Content Introduction Presentation of Correlation Network Harm Reduction in a nutshell basic principles and critical

More information

The impact of economic recession on drug users and drug treatment

The impact of economic recession on drug users and drug treatment The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry

More information

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

Poland nationalupdate

Poland nationalupdate Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in

More information

Hepatitis B Virus and the Opioid Crisis

Hepatitis B Virus and the Opioid Crisis Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers

More information

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? Cinta Folch on behalf of REDAN Study Group Viral Hepatitis Prevention

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative

More information

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics

More information

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use,

From Fix to Foil. The Dutch experience in promoting transition away from injecting drug use, From Fix to Foil The Dutch experience in promoting transition away from injecting drug use, 1991-2009 International Harm Reduction Conference Liverpool, April 2010 John-Peter Kools Contents 1. Dutch context

More information

COUNTRY TABLE. MONTENEGRO.

COUNTRY TABLE. MONTENEGRO. EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI

More information

Most recent data, analyses and feed-back from the 2016 DRID national updates

Most recent data, analyses and feed-back from the 2016 DRID national updates Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID

More information

Hepatitis prevention in the context of HIV prevention point work in Latvia

Hepatitis prevention in the context of HIV prevention point work in Latvia Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;

More information

Harm Reduction in Nigeria

Harm Reduction in Nigeria Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous

More information

Recent trends in drug problems and service provision in Greece

Recent trends in drug problems and service provision in Greece Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug

More information

Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate

Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate What is a DCR? A facility that allows people to inject/smoke illicitly purchased drugs,

More information

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases

More information

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public

More information

Signs of success latest national NESI data?

Signs of success latest national NESI data? Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

QuADS Organisational Standards and Professional Competencies in needle exchange

QuADS Organisational Standards and Professional Competencies in needle exchange QuADS Organisational Standards and Professional Competencies in needle exchange N This briefing paper was funded by the Department of Health as part of their 'Making Harm Reduction Work' initiative. DrugScope/Department

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

Felice Nava, MD, PhD Felice A. Nava, MD PhD

Felice Nava, MD, PhD Felice A. Nava, MD PhD Felice Nava, MD, PhD Felice A. Nava, MD PhD Direttore U.O. Sanità Penitenziaria Azienda ULSS 6 Euganea Padova Direttore Comitato Scientifico Nazionale FeDerSerD HCV 0? Dall Eradicazione del virus alla

More information

Targeted Outreach & Other Strategies for Increasing HCV Testing

Targeted Outreach & Other Strategies for Increasing HCV Testing Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department

More information

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives

More information

Prevention of and Immunisation against Hepatitis B and C

Prevention of and Immunisation against Hepatitis B and C Prevention of and Immunisation against Hepatitis B and C January 2014 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Demonstrate an increased knowledge and

More information

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg

More information

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,

More information

Historical Perspectives

Historical Perspectives Why Harm Reduction? 1 Rochelle Head-Dunham, MD FAPA Executive Director and Medical Director Metropolitan Human Services District Clinical Associate Professor of Psychiatry LSU and Tulane Historical Perspectives

More information

Hepatitis C Strategy. About us. What is hepatitis C?

Hepatitis C Strategy. About us. What is hepatitis C? Hepatitis C Strategy About us We support people to take control of their lives and make positive changes. For fifty years we have made a difference to people who want to change their relationship with

More information

First results collected by Argos, DCR in Strasbourg opened in november 2016

First results collected by Argos, DCR in Strasbourg opened in november 2016 Photo Marine Saiah First results collected by Argos, DCR in Strasbourg opened in november 2016 Danièle BADER, Leader of Ithaque Association EMCDDA, DRID Meeting 18-20 september 2017 A crossborder experimentation

More information

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas New EU Health Programme: funding mechanisms for civil society working on HIV and related areas Cinthia Menel Lemos Think Tank meeting Luxembourg, 10 December 2013 Executive Agency for Health and Consumers

More information

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*

More information

CitiWide Harm Reduction

CitiWide Harm Reduction CitiWide Harm Reduction Ryan White Part A Harm Reduction Services: AOD Services Conflict of Interest Disclosure: CitiWide Harm Reduction currently has an HRR contract: 07-HRR HRR-748 Presentation to the

More information

Promoting hepatitis B vaccination

Promoting hepatitis B vaccination Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis

More information

Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations

Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations Drug demand reduction and harm reduction: complementary approaches Gilberto Gerra Chief Global Challenges Section Division for Operations The comprehensive approach: no contrast, but synergism, between

More information

High Impact Prevention for People Who Inject Drugs. June 30, 2015

High Impact Prevention for People Who Inject Drugs. June 30, 2015 High Impact Prevention for People Who Inject Drugs June 30, 2015 Webinar Agenda Introduction & Background o NASTAD Drug User Health: Challenges and Opportunities for Health Departments o Alessandra Ross,

More information

What is harm reduction?

What is harm reduction? What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive

More information

Becoming a harm reduction distribution agency in Toronto - information session

Becoming a harm reduction distribution agency in Toronto - information session Becoming a harm reduction distribution agency in Toronto - information session Kris Guthrie, RN BScN Health Promotion Specialist, The Works Toronto Public Health May 2016 Overview Brief backgrounder Harm

More information

Prevention of and Immunisation against Hepatitis B and C

Prevention of and Immunisation against Hepatitis B and C Prevention of and Immunisation against Hepatitis B and C Presentation 5 January 2016 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Demonstrate an increased

More information

Addiction and Substance misuse pathways

Addiction and Substance misuse pathways Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C

More information

Prevention of and Immunisation against Hepatitis B and C

Prevention of and Immunisation against Hepatitis B and C Prevention of and Immunisation against Hepatitis B and C Presentation 5 October 2018 0 Learning Outcomes Participants will be able to: Demonstrate an increased knowledge and understanding of opportunities

More information

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009 The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle

More information

Harm reduction among drug users in Spain

Harm reduction among drug users in Spain Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández

More information

INTRAVENOUS INJECTING DRUG USE.

INTRAVENOUS INJECTING DRUG USE. Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been

More information

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information

Thirty years of harm reduction in the Netherlands HCV elimination ahead?

Thirty years of harm reduction in the Netherlands HCV elimination ahead? Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther

More information

Needle Exchange Programs

Needle Exchange Programs Needle Exchange Programs Are they right for your community? Deena Dodd Indiana Rural Health Association 2017 Indiana General Assembly House Bill #1438 Syringe exchange programs: Allows a county or municipality

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia

Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia Differences by country of origin and by gender among people who inject drugs attending low threshold agencies in Catalonia Folch C 1,3, Casabona J 1,3, Espelt A 2,3, Major X 4, Meroño M 5, Gonzalez V 1,6,

More information

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program. This guide is designed to help Community-Based Organizations (CBOs) and other individuals or groups in the planning and implementation of a Mobile Outreach Vehicle (MOV)-based risk-reduction intervention

More information

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Plain-language summary The health needs of people who inject drugs in public places in Glasgow

More information

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly

More information

Substance use and misuse

Substance use and misuse CENTRE FOR PHARMACY POSTGRADUATE EDUCATION Substance use and misuse A CPPE workshop to support local public health services Pre-workshop book PH/SUBSUSE14/PW August 2014 Substance use and misuse - Pre-workshop

More information

Harm Reduction Database Wales: Needle and Syringe provision

Harm Reduction Database Wales: Needle and Syringe provision Harm Reduction Database Wales: Needle and Syringe provision 2012-13 Public Health Wales would like to thank all those that contributed to the Harm Reduction Database Wales: NSP service users, NSP staff

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total

More information

Hepatitis C Elimination Program Georgia

Hepatitis C Elimination Program Georgia Hepatitis C Elimination Program Georgia Maia Butsashvili, MD, MS, PhD Health Research Union (HRU)/Clinic NEOLAB National HCV Committee International School of Public Health High prevalence of HCV in Georgia

More information

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

National HIV Behavioral Surveillance Portland, Oregon

National HIV Behavioral Surveillance Portland, Oregon National HIV Behavioral Surveillance Portland, Oregon Tim W. Menza, MD, PhD Medical Director HIV/STD/TB Section Oregon Health Authority timothy.w.menza@state.or.us National HIV Behavioral Surveillance

More information

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE MEETING 2 JULY 21 ST, 2017 9AM-11AM 25 VAN NESS AVE RM 610 SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH AGENDA WELCOME & AGENDA REVIEW MEETING 1 FINDINGS &

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Principles and challenges of HA-REACT as an example of multilateral and multisectoral programme Mika Salminen, Ph. D, Research

More information

HIV in Prison Situation in Frankfurt am Main

HIV in Prison Situation in Frankfurt am Main HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation

More information

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in

More information

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Template Control Page Substance Misuse Newham Template Guide Title Substance Misuse Newham Author CEG Status Active Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Version Date Summary of Changes

More information

DISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017

DISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017 ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER 2016 First results and perspectives DISCLOSURE DR Elisabeth AVRIL Presentation : Espace GAIA, first DCR in Paris : first results and perspectives Mundipharma,

More information

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions

More information

Prevention Point Philadelphia

Prevention Point Philadelphia Integrating Hepatitis C Prevention, Care, Education, and Referrals in a Clinical & Social Service Setting By Iredia Olaye Primary Care & HCV Outreach, Linkage & Referral Specialist Prevention Point Philadelphia

More information

Drug Use, Harm Reduction, and HIP

Drug Use, Harm Reduction, and HIP Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action Toronto Declaration: Strategies to control and eliminate viral hepatitis globally A call for coordinated action Hepatitis B National Action Plan All countries should develop a national and/or regional

More information

Greater Manchester Commissioning Guidelines for Blood Borne Virus Prevention

Greater Manchester Commissioning Guidelines for Blood Borne Virus Prevention Greater Manchester Commissioning Guidelines for Blood Borne Virus Prevention Endorsed by Greater Manchester Director of Public Health March 2011 Hepatitis Greater Manchester Hepatitis C Strategy Authors

More information

4.0 Current Service Configuration

4.0 Current Service Configuration 4.0 Current Service Configuration Adult addictions services are delegated to the Edinburgh Integration Joint Board (IJB) and the responsibility for planning and developing these services sits with the

More information

The evolution of the HIV/AIDS outbreak among IDUs in Romania

The evolution of the HIV/AIDS outbreak among IDUs in Romania The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU

More information

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund Outline How do we monitor drug trends in Australia Aims Methodology Drug

More information

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Background and affiliations BS (MIT); 3 years in international health (Mexico City and Honduras with Peace Corps); MS (Colorado State University);

More information

JSNA Substance Misuse

JSNA Substance Misuse JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour

More information

Blood-borne viruses in marginalised populations

Blood-borne viruses in marginalised populations Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis

More information

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction. Training Objectives By the end of this session you will be able to: 1. Define harm reduction. 2. Recognize key principles of harm reduction. 3. Identify the need for harm reduction, with a PWID focus.

More information

HIV AND PEOPLE WHO INJECT DRUGS

HIV AND PEOPLE WHO INJECT DRUGS UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.

More information

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria OUTLINE Harm reduction Canadian context Lessons learned 1.

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID

More information

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD Drug Policy and the HIV Movement SAULIUS CAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University 14th ECAD Mayors Conference Fighting Against Drugs - From Different

More information

APPENDIX: Key summary of six US-based naloxone distribution programs

APPENDIX: Key summary of six US-based naloxone distribution programs Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States Traci C. Green, Robert Heimer, Lauretta

More information